Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas

In addition to LVI, we could identify TB as an independent prognostic factor in p16-positive OPSCC in this multicenter study cohort. Thus, evaluating TB along with LVI in a combined scheme for prognostication might help to establish a more personalized treatment regimen for patients with p16-positive OPSCC.

Authors

Institutions

Publication Details

Journal
British Journal of Cancer
Published
2024-11-29
DOI
https://doi.org/10.1038/s41416-024-02912-3
Citations
3
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
1.74

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas

Antoniu‐Oreste Gostian, Melanie Boxberg, Lukas Lükewille, Matthias Balk et al.
3 citations
British Journal of Cancer
Head and Neck Cancer Studies
1.74
article

Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas

Antoniu‐Oreste Gostian, Melanie Boxberg, Lukas Lükewille, Matthias Balk, Barbara Wollenberg, Maren Lauterbach, Markus Hoffmann, Markus Wirth, Moritz Jesinghaus, Christoph Röcken, Iordanis Ourailidis, Benedikt Schmidl, Jochen Heß, Heinrich Iro, Sven Perner, Carolin Mogler, Fabian Stögbauer, Cosima C. Hoch, Julika Ribbat‐Idel, Markus Eckstein, Jan Budczies, Verena-Wilbeth Sailer, Arndt Hartmann, Karl‐Ludwig Bruchhage, Christiane Stuhlmann‐Laeisz
article en
3 citations

Abstract

In addition to LVI, we could identify TB as an independent prognostic factor in p16-positive OPSCC in this multicenter study cohort. Thus, evaluating TB along with LVI in a combined scheme for prognostication might help to establish a more personalized treatment regimen for patients with p16-positive OPSCC.

British Journal of CancerVol. 132(2)
Philipps University of Marburg (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), Christian-Albrechts-Universität zu Kiel (DE), Universitätsklinikum Erlangen (DE), University Hospital Schleswig-Holstein (DE), Research Center Borstel - Leibniz Lung Center (DE), Bernstein Center for Computational Neuroscience Tübingen (DE), Comprehensive Cancer Center Erlangen (DE), Technical University of Munich (DE), University of Lübeck (DE)
Technische Universität München, Deutsche Krebshilfe
Good health and well-being
Openalex Percentile: Top 15%
Head and Neck Cancer Studies
1.74
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.